137 related articles for article (PubMed ID: 29384236)
1. Incidence and risk factors associated with hepatocellular carcinoma surveillance failure.
Mancebo A; Varela M; González-Diéguez ML; Navascués CA; Cadahía V; Mesa-Álvarez A; Rodrigo L; Rodríguez M
J Gastroenterol Hepatol; 2018 Aug; 33(8):1524-1529. PubMed ID: 29384236
[TBL] [Abstract][Full Text] [Related]
2. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.
Bolondi L; Sofia S; Siringo S; Gaiani S; Casali A; Zironi G; Piscaglia F; Gramantieri L; Zanetti M; Sherman M
Gut; 2001 Feb; 48(2):251-9. PubMed ID: 11156649
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a surveillance program for early detection of hepatocellular carcinoma.
Zoli M; Magalotti D; Bianchi G; Gueli C; Marchesini G; Pisi E
Cancer; 1996 Sep; 78(5):977-85. PubMed ID: 8780534
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
[TBL] [Abstract][Full Text] [Related]
5. Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis.
Del Poggio P; Olmi S; Ciccarese F; Di Marco M; Rapaccini GL; Benvegnù L; Borzio F; Farinati F; Zoli M; Giannini EG; Caturelli E; Chiaramonte M; Trevisani F;
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1927-33.e2. PubMed ID: 24582947
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte proliferation and risk of hepatocellular carcinoma in cirrhotic patients.
Sangiovanni A; Colombo E; Radaelli F; Bortoli A; Bovo G; Casiraghi MA; Ceriani R; Roffi L; Redaelli A; Rossini A; Spinzi G; Minoli G
Am J Gastroenterol; 2001 May; 96(5):1575-80. PubMed ID: 11374702
[TBL] [Abstract][Full Text] [Related]
7. A training program for primary care physicians improves the effectiveness of ultrasound surveillance of hepatocellular carcinoma.
Del Poggio P; Olmi S; Ciccarese F; Mazzoleni M; Jazzetti M; Jamoletti C; Mattiello M; Del Poggio A; Portugali V; Stroffolini T
Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1103-8. PubMed ID: 26049705
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
[TBL] [Abstract][Full Text] [Related]
9. Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction.
Hsin IF; Hsu CY; Huang HC; Huang YH; Lin HC; Lee RC; Chiang JH; Lee FY; Huo TI; Lee SD
J Clin Gastroenterol; 2011 Jul; 45(6):556-62. PubMed ID: 21666547
[TBL] [Abstract][Full Text] [Related]
10. Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.
Santi V; Trevisani F; Gramenzi A; Grignaschi A; Mirici-Cappa F; Del Poggio P; Di Nolfo MA; Benvegnù L; Farinati F; Zoli M; Giannini EG; Borzio F; Caturelli E; Chiaramonte M; Bernardi M;
J Hepatol; 2010 Aug; 53(2):291-7. PubMed ID: 20483497
[TBL] [Abstract][Full Text] [Related]
11. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
[TBL] [Abstract][Full Text] [Related]
12. [Community-based hepatocellular carcinoma screening in seven townships in Taiwan].
Chen CJ; Lu SN; You SL; Wu MH; Wang LY; Lee LT; Huang GT; Yang PM; Lee HS
J Formos Med Assoc; 1995 Dec; 94 Suppl 2():S94-102. PubMed ID: 8672950
[TBL] [Abstract][Full Text] [Related]
13. Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma.
Mazzaferro V; Sposito C; Zhou J; Pinna AD; De Carlis L; Fan J; Cescon M; Di Sandro S; Yi-Feng H; Lauterio A; Bongini M; Cucchetti A
Gastroenterology; 2018 Jan; 154(1):128-139. PubMed ID: 28989060
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma in Lebanon: Etiology and prognostic factors associated with short-term survival.
Yaghi C; Sharara AI; Rassam P; Moucari R; Honein K; BouJaoude J; Slim R; Noun R; Abdul-Baki H; Khalifeh M; Ramia S; Sayegh R
World J Gastroenterol; 2006 Jun; 12(22):3575-80. PubMed ID: 16773714
[TBL] [Abstract][Full Text] [Related]
15. Survival improvement in Child-Pugh C cirrhotic patients with hepatocellular carcinoma diagnosed during 1990-2002.
Ollivier I; Dauvois B; Guittet L; Boutreux S; Dupont B; Launoy G; Dao T
Gastroenterol Clin Biol; 2010; 34(4-5):288-96. PubMed ID: 20189339
[TBL] [Abstract][Full Text] [Related]
16. Annual incidence of hepatocellular carcinoma among patients with alcoholic cirrhosis and identification of risk groups.
Mancebo A; González-Diéguez ML; Cadahía V; Varela M; Pérez R; Navascués CA; Sotorríos NG; Martínez M; Rodrigo L; Rodríguez M
Clin Gastroenterol Hepatol; 2013 Jan; 11(1):95-101. PubMed ID: 22982095
[TBL] [Abstract][Full Text] [Related]
17. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
18. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
[TBL] [Abstract][Full Text] [Related]
19. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
[TBL] [Abstract][Full Text] [Related]
20. Survival from hepatocellular carcinoma at a cancer hospital in Pakistan.
Yusuf MA; Badar F; Meerza F; Khokhar RA; Ali FA; Sarwar S; Faruqui ZS
Asian Pac J Cancer Prev; 2007; 8(2):272-4. PubMed ID: 17696722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]